| Literature DB >> 25180189 |
I-Hsuan Chen1, Jen-Tai Lin2, Jeng-Yu Tsai2, Tony Wu3, Chia-Cheng Yu4.
Abstract
OBJECTIVE: To present our experience with single mini-incision complete urinary tract exenteration (CUTE) for female dialysis patients suffering from urothelial carcinoma (UC). PATIENTS AND METHODS: Institutional review board approval was obtained. From 2005 through 2012, 14 female dialysis patients with UC underwent single mini-incision CUTE, in combination with radical hysterectomy and bilateral salpingo-oophorectomy. All were placed in the modified dorsal lithotomy position without repositioning. An infraumbilical midline mini-incision was made. Bilateral nephroureterectomy was first performed entirely extraperitoneally, followed by radical cystectomy with removal of the uterus and ovaries transperitoneally.Entities:
Mesh:
Year: 2014 PMID: 25180189 PMCID: PMC4142548 DOI: 10.1155/2014/649642
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Illustration of two cord-like structures passing forwards in the peritoneal fold and entering the inguinal canal by the internal ring, considered to be the round ligament or spermatic cord in the female and the male, respectively.
Figure 2Illustration of Peritoneal mobilization. After division of the round ligament, two customized long right-angle retractors (upper 2 blades), as well as a Bookwalter retractor system (lower 2 blades), are used to push the peritoneum medially and anteriorly, thereby exposing the retroperitoneum.
Figure 3Intraoperative image of Perirenal dissection. A circumferential dissection of the kidney was performed along the plane between the renal capsule and the perinephric fat, with assistance of LigaSure.
Figure 4Intraoperative image showing good exposure of the retroperitoneum and complete mobilization of the kidney.
Patient demographics and perioperative parameters.
| Pt | Age (y) | Duration of HD (yr) | BMI (kg/m2) | ECOG | Clinically surgical indication | Hydronephrosis | Pathologic tumor location (T stage)a | Comorbidity |
|---|---|---|---|---|---|---|---|---|
| 1 | 63 | 9 | 21.4 | 0 | UB & LU | Left | UB(is) & LU(1) | HTN |
| 2 | 50 | 14 | 21.7 | 0 | UB & RU | Right | UB(1) & RU(3) | HTN |
| 3 | 61 | 8 | 25.9 | 1 | UB & RU∗∗ | Right | UB(a) & RU(a) | HTN, HCC, cirrhosis, |
| 4 | 75 | 6 | 31.5 | 0 | UB & LU | Left | UB(a) & LU(a) | None |
| 5 | 63 | 17 | 17.1 | 1 | UB & LK | Bilateral | UB(1) & LK(3) | HTN, hepatitis C, |
| 6 | 52 | 4 | 31.8 | 0 | UB & RK | No | UB(1) & RK(1) | HTN, DM |
| 7 | 67 | 1 | 20.4 | 1 | BK & RU | Right | BK(a) & RU(1) | HTN, CHF |
| 8 | 80 | 6 | 17.0 | 1 | UB & LU∗∗ | Bilateral | UB(2a) & LU(a) | HTN, DM, |
| 9 | 58 | 9 | 21.3 | 1 | UB & RU | No | UB(is) & RU(1) | SHPT |
| 10 | 70 | 2 | 22.6 | 1 | UB & RU∗∗ | Right | UB(1) & RU(1) | HTN, old CVA, |
| 11 | 57 | 8 | 22.2 | 1 | UB∗∗ | Left | UB(2a) | SHPT |
| 12 | 57 | 13 | 17.3 | 1 | UB∗∗ | Left | UB(1) | Pulmonary TB |
| 13 | 53 | 10 | 21.5 | 0 | UB | No | UB(1) | HTN, hepatitis B |
| 14 | 48 | 11∗ | 21.2 | 1 | UB | Left | UB(1) | HTN, hepatitis C, |
HD, hemodialysis; BMI, body mass index; ECOG, eastern cooperative oncology group performance status; UB, urinary bladder; LU, left ureter; RU, right ureter; LK, left kidney; RK, right kidney; BK, bilateral kidney; ccRCC, clear cell renal cell carcinoma; HTN, hypertension; HCC, hepatocellular carcinoma; SHPT, secondary hyperparathyroidism; TB, tuberculosis; DM, diabetes mellitus; CHF, congestive heart failure; CVA, cardiovascular accident.
aAll patients had high-grade urothelial carcinoma.
∗Peritoneal dialysis.
∗∗Surgical indication was recurrent urothelial cancer.
∗∗∗Continuous ambulatory peritoneal dialysis (CAPD) related sclerosing peritonitis.
Comparison of outcomes from concurrent upper and lower urinary tract surgery.
| Author | Number | Extent of surgery | Age (y) | Operative time (min)a | Blood loss (mL)a | Hospital stay (d)a | Time to intake (hr)a | Complication (%)b |
|---|---|---|---|---|---|---|---|---|
|
El-Galley et al., 2011 [ | 36 | BN | N/A | 222 | 175∗∗∗ | 3.0∗∗∗ | N/A | 22.2 |
| Chueh et al., 2002 [ | 7 | BNU | 51.6 | 294∗∗ | 218∗∗ | 8.8∗ | 39.0 | 14.3 |
| Tai et al., 2009 [ | 33 | BNU | 52.4 | 309∗∗ | 226∗∗ | 10.2 | 58.0 | 12.1 |
| Ou and Yang, 2011 [ | 13 | BNU | 60.0 | 215 | 216∗∗ | 13.8 | 60.0 | 7.7 |
| Ou and Yang, 2011 [ | 10 | CUTE | 57.6 | 328∗∗∗ | 628 | 14.7∗ | 62.4∗ | 10.0 |
| Li et al., 2009 [ | 5 | CUTE | 58.0 | 492∗∗∗ | 378 | 12.2 | 72.0∗∗ | 80.0 |
| Lin et al., 2011 [ | 5 | CUTE | 66.6 | 397∗∗∗ | 532 | 10.8 | 91.2∗∗∗ | 20.0 |
| Present study | 14 | CUTE | 61.0 | 237.5 | 560.7 | 12.1 | 48.0 | 21.4 |
BN, bilateral nephrectomy; BNU, bilateral nephroureterectomy; CUTE, complete urinary tract exenteration.
aOne sample t-test.
bChi-square test.
*P < 0.005, ∗∗P < 0.01, ∗∗∗P < 0.001 for compared to present study.
N/A, not available.